Decibel Therapeutics Revenue

Biotechnology Research • Boston, Massachusetts, United States • 1-10 Employees

Decibel Therapeutics revenue & valuation

Annual revenue	$12,500,000
Revenue per employee	$1,389,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$40,000,000
Total funding	$82,200,000

Key Contacts at Decibel Therapeutics

Tyler Gibson

Senior Director

Ning Pan

Director

Noah Druckenbrod

Associate Director

Company overview

Headquarters	1325 Boylston Street, Suite 500, Boston, MA 02215, US
Phone number	+16173708701
Websites	decibeltx.com regeneron.com
NAICS	541714
SIC	737
Employees	1-10
Socials

Decibel Therapeutics Email Formats

Decibel Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@decibeltx.com), used 60% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@decibeltx.com	60%
{first initial}{last name}	jdoe@decibeltx.com	40%

About Decibel Therapeutics

Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine. Decibel has built a proprietary platform that integrates single-cell genomics and bioinformatic analyses, precision gene therapy technologies and expertise in inner ear biology. Decibel is leveraging its platform to advance gene therapies designed to selectively replace genes for the treatment of congenital, monogenic hearing loss and to regenerate inner ear hair cells for the treatment of acquired hearing and balance disorders. Decibel’s pipeline, including its lead gene therapy program, DB-OTO, to treat congenital, monogenic hearing loss, is designed to deliver on our vision of building a world of connection for people with hearing and balance disorders. Guidelines: https://bit.ly/3IzmNvU

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Entry

C-Suite

Employees by Department

Decibel Therapeutics has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore Decibel Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-12-09	7	$82,200,000

Funding Insights

$82,200,000

Total funding amount

$82,200,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Decibel Therapeutics is located in Boston, Massachusetts, US.

You can reach Decibel Therapeutics at +16173708701.

Decibel Therapeutics generates an estimated annual revenue of $12,500,000. This revenue figure reflects the company's market position and business performance in its industry.

Decibel Therapeutics has an estimated valuation of $40,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Decibel Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Decibel Therapeutics has raised a total of $82,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Decibel Therapeutics

Tyler Gibson

Senior Director

Ning Pan

Director

Noah Druckenbrod

Associate Director

4.8

40,000 users